Stock News

Stock Update (NASDAQ:MSFT): Oil and Gas Industry Investment in Digital Technologies Shows Resilience in Oil Price Downturn, Accenture Plc and Microsoft Corporation Survey Reports

Despite current lower crude oil prices, most companies in the oil and gas industry plan to invest the same amount or more in …

Stock Update (NASDAQ:DRWI): DragonWave, Inc.(USA) Signs Purchase Agreement for Technical Products and Related Services With Tier One North American Carrier

DragonWave, Inc.(USA) (NASDAQ:DRWI), a leading global supplier of packet microwave radio systems for mobile and access networks, today announced it has signed a …

Stock Update (NASDAQ:ARIA): ARIAD Pharmaceuticals, Inc. Announces Issuance of Key U.S. Patent on Brigatinib

ARIAD Pharmaceuticals, Inc. (NASDAQ:ARIA) announced the issuance of its first U.

Company Update (NYSE:BABA): Alibaba Group Holding Ltd Establishes Collaborative Relationships With BMW MINI and Jaguar Land Rover

Alibaba Group Holding Ltd (NYSE:BABA)’s automobile business unit today established collaborative relationships with BMW MINI and Jaguar Land Rover aimed at enhancing customers’ …

Company Update (NASDAQ:CAMP): CalAmp Corp. Reports Record Fiscal 2015 Fourth Quarter and Full Year Results

CalAmp Corp. (NASDAQ:CAMP), a leading provider of wireless products, services and solutions, today reported results for its fourth quarter and full year ended February 28, …

Stock Update (NASDAQ:GPRO): GoPro Inc to Present at Investor Conferences in May

GoPro Inc (NASDAQ:GPRO), enabler of some of today’s most engaging content, announced that it will present at the following investor conferences in May 2015: Baird’s …

Company Update (NASDAQ:ILMN): Illumina, Inc. Reports Strong Start to Fiscal Year 2015

Illumina, Inc. (NASDAQ:ILMN) announced its financial results for the first quarter of fiscal year 2015.

Company Update (NYSE MKT:RNN): New Data Show Rexahn Pharmaceuticals Inc’s Supinoxin(TM) Decreases Migration of Human Triple Negative Breast Cancer Cells in Metastatic Cancer Model

Rexahn Pharmaceuticals, Inc. (NYSE MKT:RNN), a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, announced that it presented preclinical …

Stock Update (NASDAQ:PPHM): Preclinical Data Demonstrate Anti-Tumor Effects of Peregrine Pharmaceuticals’ (PS)-Targeting Antibodies in Melanoma and Breast Cancer

Peregrine Pharmaceuticals (NASDAQ:PPHM) announced the presentation of data from preclinical studies demonstrating the combination of phosphatidylserine (PS) blockade with anti-PD-1 or anti-CTLA-4 immune …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts